ストックスクリーナーアプリを入手
3.11
0.96%
-0.03
前日終値:
$3.14
開ける：
$3.07
24時間の取引高:
3.27M
Relative Volume:
0.71
時価総額：
$824.60M
収益：
$194.75M
当期純損益:
$-51.26M
株価収益率:
-11.11
EPS:
-0.28
ネットキャッシュフロー:
$-23.38M
1週間 パフォーマンス:
+0.65%
1か月 パフォーマンス:
-16.40%
6か月 パフォーマンス:
+68.11%
1年 パフォーマンス:
+100.65%
1日の値動き範囲:
$3.05
$3.22
1週間の範囲:
$2.98
$3.22
52週間の値動き範囲:
$1.24
$4.0787
Akebia Therapeutics Inc Stock (AKBA) Company Profile
名前
Akebia Therapeutics Inc
セクター
電話
617-871-2098
住所
245 FIRST STREET, CAMBRIDGE, MA
AKBA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AKBA
Akebia Therapeutics Inc
|
3.11 | 832.56M | 194.75M | -51.26M | -23.38M | -0.28 |
|
ZTS
Zoetis Inc
|
152.88 | 69.31B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.16 | 47.34B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.76 | 43.88B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.75 | 21.08B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
404.81 | 13.78B | 2.99B | 1.21B | 1.13B | 25.06 |
Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-04 | 再開されました | H.C. Wainwright | Buy |
| 2025-04-28 | 開始されました | Leerink Partners | Outperform |
| 2025-04-01 | 開始されました | Jefferies | Buy |
| 2023-11-29 | 再開されました | BTIG Research | Buy |
| 2023-08-28 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-05-31 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-03-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-03-31 | ダウングレード | Needham | Buy → Hold |
| 2022-03-31 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-03-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-01-29 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-11-14 | 繰り返されました | Needham | Buy |
| 2019-08-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-07-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-05-02 | 開始されました | JP Morgan | Overweight |
| 2019-03-20 | 開始されました | Citigroup | Neutral |
| 2018-09-07 | 再開されました | Morgan Stanley | Equal-Weight |
| 2018-08-10 | 繰り返されました | Needham | Buy |
| 2018-06-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-12-19 | 開始されました | Piper Jaffray | Overweight |
| 2017-12-07 | 開始されました | BTIG Research | Buy |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2017-07-10 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-27 | 繰り返されました | Needham | Buy |
| 2016-12-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-12-20 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2016-11-15 | 開始されました | Aegis Capital | Buy |
| 2016-09-29 | 開始されました | Brean Capital | Buy |
| 2016-03-16 | 繰り返されました | Needham | Buy |
| 2016-01-21 | 開始されました | Credit Suisse | Neutral |
すべてを表示
Akebia Therapeutics Inc (AKBA) 最新ニュース
Using Python tools to backtest Akebia Therapeutics Inc. strategiesBond Market & Real-Time Stock Entry Alerts - Newser
Understanding Akebia Therapeutics Inc.’s price movementRecession Risk & High Return Stock Watch Alerts - Newser
Akebia Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
95,100 Shares at $3.14: Akebia Therapeutics Grants Inducement Stock Options to Key New Hires - Stock Titan
Will Akebia Therapeutics Inc. outperform the marketMarket Risk Report & AI Enhanced Execution Alerts - Newser
Stock Report: Can Akebia Therapeutics Inc. stock outperform in a bear market2025 Earnings Surprises & Accurate Buy Signal Notifications - خودرو بانک
Does Akebia Therapeutics Inc. have declining or rising EPSJuly 2025 Price Swings & Verified Momentum Stock Ideas - خودرو بانک
Analyzing drawdowns of Akebia Therapeutics Inc. with statistical toolsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - Newser
Measuring Akebia Therapeutics Inc.’s beta against major indicesTreasury Yields & Long-Term Growth Plans - Newser
Does Akebia Therapeutics Inc. have pricing powerQuarterly Risk Review & Low Risk Profit Maximizing Plans - خودرو بانک
Can Akebia Therapeutics Inc. stock outperform in a bear marketMarket Growth Review & High Win Rate Trade Tips - خودرو بانک
What is Akebia Therapeutics Inc. s 5 year growth outlookEarnings Growth Report & Weekly Setup with ROI Potential - خودرو بانک
Regression analysis insights on Akebia Therapeutics Inc. performance2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Akebia Therapeutics Inc. Stock Recovery Path — Analyst Breakdown2025 Momentum Check & Stock Market Timing Techniques - beatles.ru
Is Akebia Therapeutics Inc. reversing from oversold territoryJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
Is Akebia Therapeutics Inc. forming a bottoming baseJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - Newser
How moving averages guide Akebia Therapeutics Inc. tradingMarket Trend Summary & Reliable Momentum Entry Alerts - Newser
Visual trend scoring systems applied to Akebia Therapeutics Inc.Market Trend Review & Free Reliable Trade Execution Plans - Newser
Using Bollinger Bands to evaluate Akebia Therapeutics Inc.2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Using Ichimoku Cloud for Akebia Therapeutics Inc. technicalsMarket Activity Report & Weekly Chart Analysis and Guides - Newser
Why Akebia Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Breakouts & High Conviction Trade Alerts - Newser
What Fibonacci levels say about Akebia Therapeutics Inc. reboundJuly 2025 Sector Moves & Safe Swing Trade Setups - Newser
How to interpret RSI for Akebia Therapeutics Inc. stockEarnings Trend Report & Verified Entry Point Signals - Newser
Elliott Wave Theory Predicts Pullback in Akebia Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Strategies to average down on Akebia Therapeutics Inc.2025 Sector Review & Proven Capital Preservation Methods - Newser
Sentiment analysis tools applied to Akebia Therapeutics Inc.Market Growth Summary & AI Driven Stock Price Forecasts - Newser
Earnings Chart Overlay Points to Akebia Therapeutics Inc. UpsideJuly 2025 Trade Ideas & Reliable Price Action Trade Plans - beatles.ru
Biotech Movers: Akebia Shares Down After Pricing Stock Offering - TheStreet
What’s the recovery path for long term holders of Akebia Therapeutics Inc.Volume Spike & Safe Capital Growth Tips - Newser
Price momentum metrics for Akebia Therapeutics Inc. explainedPortfolio Gains Summary & Expert Curated Trade Setups - Newser
Chart based exit strategy for Akebia Therapeutics Inc.Portfolio Gains Summary & Low Risk High Win Rate Picks - Newser
Akebia Therapeutics Inc (AKBA) 財務データ
収益
当期純利益
現金流量
EPS
1.48%
2.72%
大文字化:
|
ボリューム (24 時間):